This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by MANNELLI, M. Articles by GIUSTI, G. Search for Related Content PubMed PubMed Citation Articles by MANNELLI, M. Articles by GIUSTI, G.

Opioid Modulation of Normal and Pathological Human Chromaffin Tissue^*

Endocrinology Unit, University of Florence 50134 Florence, Italy
Institute of Semeiotica University of Padua 35100 Padua, Italy

Address requests for reprints to Massimo Mannelli, M.D., Endocri-nology Unit, University of Florence, Viale Morgagni 85,50134 Florence, Italy.

To evaluate whether opioid receptor blockade might modulate sympathetic-adrenal activity, we studied the effects of placebo or naloxone administration on plasma cate-cholamine (CA) levels in a group of 13 normal subjects and 15 hypertensive patients suspected to have a pheochromocytoma. Diagnostic evaluation confirmed the presence of pheochromo-cytoma in 9 patients. Among these, 4 had a unilateral epinephrine (E)-secreting tumor, 3 had bilateral E-secreting tumors due t o multiple endocrine adenomatosis type Ha, and 2 had a unilateral norepinephrine (NE)-secreting tumor. In each subject studied, CA secretion was evaluated by calculating the area (0–30 min) under the plasma hormone curves after placebo or naloxone administratibn. In normal subjects naloxone caused a significant increase (P < 0.005) of E secretion, whereas NE did not change. Similarly, in the group of hypertensive patients, E secretion increased after naloxone (P < 0.01). In pheochromo-cytoma patients naloxone caused a significant increase in E (P < 0.05) and NE (P < 0.01) secretion from E-producing tumors but no increase in the patients with NE-secreting pheochromo-cytomas. The study suggests that CA secretion from normal and pathological chromaffin tissue is modulated by endogenous opioids; this modulation seems particularly evident in patients with E-secreting pheochromocytoma.

^* This work fiancially supported in part by Fidia Farmaceutici, Abano Terme, Italy.

Received July 1, 1985.

This article has been cited by other articles:

				E. Dermitzaki, A. Gravanis, M. Venihaki, C. Stournaras, and A. N. Margioris Opioids Suppress Basal and Nicotine-Induced Catecholamine Secretion Via a Stabilizing Effect on Actin Filaments Endocrinology, May 1, 2001; 142(5): 2022 - 2031. [Abstract] [Full Text]